105 related articles for article (PubMed ID: 24974976)
1. Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era.
Sato A; Nakamura N; Kojima M; Ohmachi K; Carreras J; Kikuti YY; Numata H; Ohgiya D; Tazume K; Amaki J; Moriuchi M; Miyamoto M; Aoyama Y; Kawai H; Ichiki A; Hara R; Kawada H; Ogawa Y; Ando K
Cancer Sci; 2014 Sep; 105(9):1170-5. PubMed ID: 24974976
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal gammopathies regardless of subtypes are associated with poor prognosis of diffuse large B-cell lymphoma: A STROBE-compliant article.
Zhang Y; Wei Z; Li J; Gao R; Liu P
Medicine (Baltimore); 2018 Jul; 97(30):e11719. PubMed ID: 30045337
[TBL] [Abstract][Full Text] [Related]
3. Estimating the global burden of Epstein-Barr virus-related cancers.
Wong Y; Meehan MT; Burrows SR; Doolan DL; Miles JJ
J Cancer Res Clin Oncol; 2022 Jan; 148(1):31-46. PubMed ID: 34705104
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma.
Chao C; Silverberg MJ; Martínez-Maza O; Chi M; Abrams DI; Haque R; Zha HD; McGuire M; Xu L; Said J
Clin Cancer Res; 2012 Sep; 18(17):4702-12. PubMed ID: 22711707
[TBL] [Abstract][Full Text] [Related]
5. Treatment of diffuse large B cell lymphoma.
Kwak JY
Korean J Intern Med; 2012 Dec; 27(4):369-77. PubMed ID: 23269875
[TBL] [Abstract][Full Text] [Related]
6. The biology and treatment of Epstein-Barr virus-positive diffuse large B cell lymphoma, NOS.
Li JW; Deng C; Zhou XY; Deng R
Heliyon; 2024 Jan; 10(1):e23921. PubMed ID: 38234917
[TBL] [Abstract][Full Text] [Related]
7. Presence of Epstein-Barr virus (EBV) antigens detected by sensitive methods has no influence on local immune environment in diffuse large B cell lymphoma.
Mangiaterra T; Alonso-Alonso R; Rabinovich A; De Dios Soler M; Galluzzo L; Soria M; Colli S; De Matteo E; Rodriguez Pinilla SM; Chabay P
Cancer Immunol Immunother; 2024 Jan; 73(2):29. PubMed ID: 38280007
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus positive diffuse large B-cell lymphoma transformed into angioimmunoblastic T-cell lymphoma after treatment.
Wang C; Gong Y; Jiang Q; Liang X; Chen R
Clin Case Rep; 2021 May; 9(5):e04083. PubMed ID: 34084501
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified.
Bourbon E; Maucort-Boulch D; Fontaine J; Mauduit C; Sesques P; Safar V; Ferrant E; Golfier C; Ghergus D; Karlin L; Lazareth A; Bouafia F; Pica GM; Orsini-Piocelle F; Rocher C; Gros FX; Parrens M; Dony A; Rossi C; Ghesquières H; Bachy E; Traverse-Glehen A; Sarkozy C
Blood Adv; 2021 Aug; 5(16):3227-3239. PubMed ID: 34427583
[TBL] [Abstract][Full Text] [Related]
10. Survival outcomes of patients newly diagnosed with diffuse large B-cell lymphoma: real-world evidence from a German claims database.
Borchmann P; Heger JM; Mahlich J; Papadimitrious MS; Riou S; Werner B
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7091-7101. PubMed ID: 36871091
[TBL] [Abstract][Full Text] [Related]
11. Estimating the prevalence of Epstein-Barr virus in primary gastric lymphoma: a systematic review and meta-analysis.
Hirabayashi M; Traverse-Glehen A; Combes JD; Clifford GM; de Martel C
Infect Agent Cancer; 2023 Feb; 18(1):8. PubMed ID: 36765388
[TBL] [Abstract][Full Text] [Related]
12. Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era.
Tao L; Clarke CA; Rosenberg AS; Advani RH; Jonas BA; Flowers CR; Keegan THM
Br J Haematol; 2017 Jul; 178(1):72-80. PubMed ID: 28542862
[TBL] [Abstract][Full Text] [Related]
13. Survival after diffuse large B-cell lymphoma among children, adolescents, and young adults in California, 2001-2014: A population-based study.
Abrahão R; Ribeiro RC; Lichtensztajn DY; Rosenberg AS; Keegan THM
Pediatr Blood Cancer; 2019 Apr; 66(4):e27559. PubMed ID: 30511461
[TBL] [Abstract][Full Text] [Related]
14. Cytological Features of Fibrin-associated Diffuse Large B-cell Lymphoma Arising in Retroperitoneal Pseudocyst: The First Case Report.
Na K; Kim SW; Kim HS
In Vivo; 2024; 38(3):1477-1482. PubMed ID: 38688594
[TBL] [Abstract][Full Text] [Related]
15. EPSTEIN -BARR VIRUS ASSOCIATION WITH MALIGNANT LYMPHOMA SUBGROUPS IN ZARIA, NIGERIA.
Iliyasu Y; Ayers LW; Liman AA; Waziri GD; Shehu SM
Niger J Surg Sci; 2014; 23(1):6-8. PubMed ID: 25620871
[TBL] [Abstract][Full Text] [Related]
16. Epstein-barr virus-negative post-transplant lymphoproliferative diseases: three distinct cases from a single center.
Bakanay SM; Kaygusuz G; Topçuoğlu P; Sengül S; Tunçalı T; Keven K; Kuzu I; Uysal A; Arat M
Turk J Haematol; 2014 Mar; 31(1):79-83. PubMed ID: 24764734
[TBL] [Abstract][Full Text] [Related]
17. CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy.
Wang WT; Xing TY; Du KX; Hua W; Guo JR; Duan ZW; Wu YF; Wu JZ; Li Y; Yin H; Shen HR; Wang L; Li JY; Liang JH; Xu W
Cancer Lett; 2024 Feb; 583():216616. PubMed ID: 38211650
[TBL] [Abstract][Full Text] [Related]
18. EBV Positive Diffuse Large B Cell Lymphoma and Chronic Lymphocytic Leukemia Patients Exhibit Increased Anti-dUTPase Antibodies.
Williams M; Ariza ME
Cancers (Basel); 2018 May; 10(5):. PubMed ID: 29723986
[TBL] [Abstract][Full Text] [Related]
19. A case of EBV-associated adrenal leiomyoma.
Takemoto T; Kiriyama I; Sugawara Y; Abe C; Teramoto N; Hashine K; Yoshida I; Asagi A
Radiol Case Rep; 2024 Jun; 19(6):2224-2229. PubMed ID: 38523717
[TBL] [Abstract][Full Text] [Related]
20. Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era.
Tao L; Foran JM; Clarke CA; Gomez SL; Keegan TH
Blood; 2014 Jun; 123(23):3553-62. PubMed ID: 24705494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
